Development of Quantitative Detection Assays for CYR61 as a New Marker for Benign Prostatic Hyperplasia
Open Access
- 1 December 2003
- journal article
- other
- Published by Elsevier in SLAS Discovery
- Vol. 8 (6) , 701-711
- https://doi.org/10.1177/1087057103259159
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Does the prostatic vascular system contribute to the development of benign prostatic hyperplasia?Current Urology Reports, 2002
- Expression of CYR61, an Angiogenic Immediate Early Gene, in Arteriosclerosis and Its Regulation by Angiotensin IICirculation, 2002
- Identification of integrin αMβ2 as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesionsBlood, 2002
- Symptomatic and asymptomatic benign prostatic hyperplasia: Molecular differentiation by using microarraysProceedings of the National Academy of Sciences, 2002
- Cyr61, a Member of the CCN Family, Is Required for MCF-7 Cell Proliferation: Regulation by 17β-Estradiol and Overexpression in Human Breast CancerEndocrinology, 2001
- NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issuesMolecular Pathology, 2001
- Integrin SignalingScience, 1999
- High-Throughput Screening for Ligand-Induced c-fos mRNA Expression by Branched DNA Assay in Chinese Hamster Ovary CellsAnalytical Biochemistry, 1999
- The Human Analog of Murine Cystein Rich Protein 16 Is a 1α,25-Dihydroxyvitamin D3 Responsive Immediate Early Gene in Human Fetal Osteoblasts: Regulation by Cytokines, Growth Factors, and Serum*Endocrinology, 1998
- Human CYR61-mediated enhancement of bFGF-induced DNA synthesis in human umbilical vein endothelial cellsOncogene, 1998